1
00:00:02,400 --> 00:00:06,760
Speaker 1: Bloomberg Audio Studios, Podcasts, Radio News.

2
00:00:07,040 --> 00:00:09,120
Speaker 2: Look, we've got to talk about the impact of generative

3
00:00:09,119 --> 00:00:12,879
Speaker 2: AI in real life across industries, Biofarmer being one of them,

4
00:00:13,119 --> 00:00:14,920
Speaker 2: and I'm priessed to welcome with the show Paul Hudson,

5
00:00:15,040 --> 00:00:18,840
Speaker 2: CEO of Sanofi, discuss how your enormous French her Farmer

6
00:00:18,880 --> 00:00:22,680
Speaker 2: company has been leveraging the new technology in its operations.

7
00:00:23,000 --> 00:00:26,200
Speaker 2: And yes, there's drug discovery, but also what's so interesting, Paul,

8
00:00:26,280 --> 00:00:29,080
Speaker 2: is you're integrating it within the functionality of your business

9
00:00:29,080 --> 00:00:30,680
Speaker 2: on a day to day basis.

10
00:00:31,280 --> 00:00:33,560
Speaker 1: Yeah, thank you, and it's a pleasure to be here.

11
00:00:33,600 --> 00:00:34,440
Speaker 1: We're really trying.

12
00:00:34,280 --> 00:00:36,960
Speaker 3: To do incredible things for patients and discovering new medicines

13
00:00:37,000 --> 00:00:40,320
Speaker 3: and you know, with AI being the great disruptor and

14
00:00:40,400 --> 00:00:43,360
Speaker 3: all of the excitement last year, the wow of large

15
00:00:43,400 --> 00:00:45,680
Speaker 3: anguige models, and this year for us, it's all about

16
00:00:45,680 --> 00:00:48,400
Speaker 3: the how and how we can get our you know,

17
00:00:48,520 --> 00:00:52,760
Speaker 3: the large amounts of our organization focused whether you're in

18
00:00:53,159 --> 00:00:56,840
Speaker 3: a lab doing expert AI, whether using generative AI in

19
00:00:57,480 --> 00:01:02,480
Speaker 3: regulatory or text driven of our business and importantly snackable

20
00:01:02,480 --> 00:01:05,360
Speaker 3: AI when we're looking at really trying to give better

21
00:01:05,400 --> 00:01:09,360
Speaker 3: decision intelligence for almost everybody in the organization with the

22
00:01:09,480 --> 00:01:12,759
Speaker 3: sole intent of becoming much more efficient effective in delivering

23
00:01:12,800 --> 00:01:13,160
Speaker 3: new meds.

24
00:01:13,200 --> 00:01:13,920
Speaker 1: And it's amazing.

25
00:01:13,959 --> 00:01:16,880
Speaker 2: Really, I love this snackable AI you're using play it's

26
00:01:16,920 --> 00:01:19,320
Speaker 2: a proprietary app. But I've got to ask sort of,

27
00:01:19,560 --> 00:01:22,600
Speaker 2: how have you thought about which underlying large language model

28
00:01:22,600 --> 00:01:24,840
Speaker 2: you should look to. How you integrate this do you

29
00:01:24,880 --> 00:01:27,560
Speaker 2: go to outsourced do you build it from within.

30
00:01:27,400 --> 00:01:32,520
Speaker 3: Pol Well, we're drug discoverers and developers, we're not coders

31
00:01:32,600 --> 00:01:35,720
Speaker 3: at our heart. So we have this first of its

32
00:01:35,800 --> 00:01:39,880
Speaker 3: kind relationship now with open AI, partnership with Formation bio

33
00:01:39,959 --> 00:01:42,680
Speaker 3: translating that for is to make sure that we can

34
00:01:42,720 --> 00:01:46,520
Speaker 3: be customizing large language models to look at drug discovery,

35
00:01:46,880 --> 00:01:50,880
Speaker 3: to try and drug undruggable diseases. To this point, and

36
00:01:50,920 --> 00:01:53,720
Speaker 3: we're doing things that have really never been done before.

37
00:01:53,760 --> 00:01:57,559
Speaker 3: It's early days, but it's extremely promising. And remember there's

38
00:01:57,600 --> 00:02:00,400
Speaker 3: such a large amount of diseases that don't have medsons

39
00:02:00,400 --> 00:02:02,640
Speaker 3: available for them because we simply have not had the

40
00:02:02,680 --> 00:02:06,760
Speaker 3: computing pairer of the opportunity to deploy ourselves. And now

41
00:02:07,040 --> 00:02:10,440
Speaker 3: just now we're at this next great revolution in science.

42
00:02:10,520 --> 00:02:12,920
Speaker 3: It's such a privilege actually to lead a company at

43
00:02:12,919 --> 00:02:17,519
Speaker 3: this point. As for play, our sort of snackable approach,

44
00:02:18,040 --> 00:02:22,000
Speaker 3: we partnered with a small startup out of Germany, a Ley.

45
00:02:22,360 --> 00:02:25,200
Speaker 3: They've been working withthers, They've grown weathers and that's, by

46
00:02:25,200 --> 00:02:26,480
Speaker 3: the way, open for everybody.

47
00:02:26,560 --> 00:02:28,560
Speaker 1: We don't own it, were having to share it.

48
00:02:28,600 --> 00:02:31,239
Speaker 3: We want all boats to rise win healthcare after all,

49
00:02:31,560 --> 00:02:34,440
Speaker 3: and so the more users, the more fun, the more accuracy,

50
00:02:34,680 --> 00:02:36,320
Speaker 3: the more chance to discovering new medicines.

51
00:02:36,480 --> 00:02:39,359
Speaker 2: So have your talent reacted because there's so much do

52
00:02:39,600 --> 00:02:41,760
Speaker 2: mongering that AI is going to take all our jobs.

53
00:02:43,520 --> 00:02:45,880
Speaker 3: Well, I think our approach has been how to weaponize

54
00:02:45,880 --> 00:02:47,080
Speaker 3: our people to do better.

55
00:02:47,160 --> 00:02:49,240
Speaker 1: Like you know, I don't know whether you're familiar with.

56
00:02:49,160 --> 00:02:51,840
Speaker 3: Ways, the driving app, but I see it very much

57
00:02:51,960 --> 00:02:53,720
Speaker 3: like that. I got to get in the car. I'm

58
00:02:53,720 --> 00:02:55,360
Speaker 3: going to start the engine and drive to the end

59
00:02:55,400 --> 00:02:58,520
Speaker 3: of the street. And if Ways says I'm statistically more

60
00:02:58,639 --> 00:03:01,320
Speaker 3: likely to have an easier journey turning left rather than

61
00:03:01,400 --> 00:03:05,080
Speaker 3: turning right, I want that advice as crowdsource large data,

62
00:03:05,120 --> 00:03:07,720
Speaker 3: real time. I want our people to feel they are

63
00:03:08,120 --> 00:03:10,120
Speaker 3: amplified or multiplied in that event.

64
00:03:10,600 --> 00:03:14,120
Speaker 1: In that event too, The goal is not about less people.

65
00:03:14,160 --> 00:03:17,079
Speaker 3: The goal is about putting our people to be more

66
00:03:17,120 --> 00:03:20,680
Speaker 3: effective and to make and to have better decision intelligence

67
00:03:20,720 --> 00:03:23,720
Speaker 3: that in itself gives us a great opportunity to do

68
00:03:23,800 --> 00:03:28,480
Speaker 3: something incredible. And we've only seen huge Appetite's why on

69
00:03:28,560 --> 00:03:32,360
Speaker 3: any given day we have eighteen thousand people in our

70
00:03:32,480 --> 00:03:35,320
Speaker 3: organization using the EI we make available and I think

71
00:03:35,360 --> 00:03:36,440
Speaker 3: that's pretty fantastic.

72
00:03:36,880 --> 00:03:40,160
Speaker 2: Let's talk about doing the amazing the incredible, because we

73
00:03:40,240 --> 00:03:42,760
Speaker 2: have just seen a push up in your share price

74
00:03:42,800 --> 00:03:45,680
Speaker 2: on the day and you've been reorientating this business of

75
00:03:45,760 --> 00:03:48,760
Speaker 2: Sonofye and thinking about more R and D, about drug

76
00:03:48,760 --> 00:03:52,440
Speaker 2: discovery and applicate and look some costly cases in the

77
00:03:52,480 --> 00:03:54,800
Speaker 2: way that you have to experiment do clinical trials, but

78
00:03:54,840 --> 00:03:56,880
Speaker 2: they've paid off today and we think about the drug

79
00:03:56,880 --> 00:04:00,480
Speaker 2: discovery when it comes to a key lung chronic lung disorder.

80
00:04:00,520 --> 00:04:01,760
Speaker 2: Can you just tell us about what that means to

81
00:04:01,800 --> 00:04:02,240
Speaker 2: the business.

82
00:04:03,000 --> 00:04:06,680
Speaker 3: Well, in Europe, just yesterday today we got approval for

83
00:04:06,840 --> 00:04:10,320
Speaker 3: chronic constructive coon me disease. COPD picks a huge number

84
00:04:10,320 --> 00:04:13,119
Speaker 3: of people third biggest killer. We're ready to go now

85
00:04:13,160 --> 00:04:15,840
Speaker 3: in Europe to be able to provide an advanced therapy

86
00:04:15,840 --> 00:04:17,920
Speaker 3: that will reduce their chance to go to hospital by

87
00:04:18,160 --> 00:04:20,680
Speaker 3: a third, and that's a breakthrough.

88
00:04:20,200 --> 00:04:21,479
Speaker 1: And there's been so little innovation.

89
00:04:22,120 --> 00:04:24,599
Speaker 3: We aspire to be the world's leading immnology company, and

90
00:04:24,640 --> 00:04:28,200
Speaker 3: that's partly driven by moments like that that we live

91
00:04:28,279 --> 00:04:31,520
Speaker 3: for in our industry to do things that transform or

92
00:04:31,560 --> 00:04:34,159
Speaker 3: protect patients lives, will prevent disease.

93
00:04:34,720 --> 00:04:34,960
Speaker 1: You know.

94
00:04:35,200 --> 00:04:39,480
Speaker 3: The reality is we're a very proud, huge, big company,

95
00:04:39,560 --> 00:04:42,440
Speaker 3: but we wanted to be at the forefront of science

96
00:04:42,440 --> 00:04:45,279
Speaker 3: again and we've made some big bets, but appropriately so

97
00:04:45,520 --> 00:04:47,719
Speaker 3: to try and make sure our science is some of

98
00:04:47,839 --> 00:04:50,760
Speaker 3: the most exciting and it's first in class or best

99
00:04:50,800 --> 00:04:53,880
Speaker 3: in class. And to couple it with our conversation of earlier,

100
00:04:53,880 --> 00:04:56,360
Speaker 3: the more we add AI, the more we improve our

101
00:04:56,400 --> 00:05:00,240
Speaker 3: decision intelligence, the more opportunity we have to do more

102
00:05:00,240 --> 00:05:02,719
Speaker 3: in that space. And I think that's what's catching the

103
00:05:02,760 --> 00:05:07,000
Speaker 3: excitement in our organization, and we believe we're quite far ahead.

104
00:05:07,040 --> 00:05:09,640
Speaker 3: I mean, of course, we're very responsible about how we

105
00:05:10,000 --> 00:05:12,360
Speaker 3: use AI, but others are still hesitating.

106
00:05:12,400 --> 00:05:15,120
Speaker 1: We're taking our moment, but sometimes you need.

107
00:05:15,040 --> 00:05:18,359
Speaker 2: Good data to feed in to these large language models. Paul,

108
00:05:18,680 --> 00:05:21,280
Speaker 2: what about the data on viruses such as well bird

109
00:05:21,320 --> 00:05:24,800
Speaker 2: flu At the moment here in the UK and the US. Indeed, Look,

110
00:05:24,839 --> 00:05:26,680
Speaker 2: there is a worry that the data hasn't been good

111
00:05:26,800 --> 00:05:28,720
Speaker 2: enough in the United States. Is that something that worries

112
00:05:28,839 --> 00:05:30,880
Speaker 2: you and you need to be developing a new vaccine

113
00:05:30,880 --> 00:05:31,080
Speaker 2: for that.

114
00:05:32,279 --> 00:05:34,760
Speaker 3: Look, I mean we've been through one pandemic. I think

115
00:05:34,760 --> 00:05:36,680
Speaker 3: we've learned a great deal about trying to have the

116
00:05:36,720 --> 00:05:39,680
Speaker 3: best data, and I think we position ourselves to take

117
00:05:39,680 --> 00:05:42,600
Speaker 3: advantage of those opportunities on behalf of society. Frankly, we

118
00:05:42,640 --> 00:05:46,119
Speaker 3: played a part small part in COVID, but we stand

119
00:05:46,200 --> 00:05:49,159
Speaker 3: ready should we be asked the data and it's legitimacy,

120
00:05:49,279 --> 00:05:52,040
Speaker 3: you know. We often that data comes in through government channels,

121
00:05:52,040 --> 00:05:54,679
Speaker 3: through health systems, you know, and we work at real

122
00:05:54,960 --> 00:05:58,120
Speaker 3: time speed to make sure that we have the very

123
00:05:58,240 --> 00:06:01,799
Speaker 3: best data available in terms of large language models and

124
00:06:01,960 --> 00:06:04,080
Speaker 3: the rest of the data sets.

125
00:06:04,400 --> 00:06:06,320
Speaker 1: You know, we collaborate far and wide.

126
00:06:06,360 --> 00:06:10,159
Speaker 3: We have punishes with oak in with ADOM, wise with excyensia.

127
00:06:10,320 --> 00:06:12,960
Speaker 3: We really are trying to make sure that we have

128
00:06:13,480 --> 00:06:15,720
Speaker 3: at our fingertips huge data sets.

129
00:06:15,760 --> 00:06:17,680
Speaker 1: To mean, our accuracy.

130
00:06:17,320 --> 00:06:20,240
Speaker 3: And our predictive capability is far ahead of the competition.

131
00:06:20,480 --> 00:06:23,919
Speaker 3: We won't get it right everywhere, but the data integrity

132
00:06:24,120 --> 00:06:27,839
Speaker 3: of the absolute fundamental start in place. Our relationship with

133
00:06:27,920 --> 00:06:30,600
Speaker 3: open AI and with Formation by It, we're putting our

134
00:06:30,640 --> 00:06:34,080
Speaker 3: own data at play to make sure that they can

135
00:06:34,160 --> 00:06:35,000
Speaker 3: learn from it too.

136
00:06:35,080 --> 00:06:37,560
Speaker 1: Again, all boats your rights. We're in healthcare to do good.

137
00:06:38,200 --> 00:06:40,599
Speaker 2: You're also selling off bits of healthcare because you're focusing

138
00:06:40,680 --> 00:06:42,479
Speaker 2: in on the R and D, the drug side, and

139
00:06:42,520 --> 00:06:45,640
Speaker 2: maybe the consumer business goes for a hefty price tag.

140
00:06:45,720 --> 00:06:48,520
Speaker 2: You've been thinking about IPO and you've been thinking about sale.

141
00:06:49,000 --> 00:06:50,320
Speaker 2: How is that process going poor?

142
00:06:51,200 --> 00:06:53,320
Speaker 3: Well, we announced that October that we were going to

143
00:06:53,320 --> 00:06:55,120
Speaker 3: become a pure play by a Farmer. You know, we

144
00:06:55,160 --> 00:06:57,320
Speaker 3: want to double down on the things we just talked about,

145
00:06:57,320 --> 00:07:02,719
Speaker 3: and we have an incredibly successful and energize consumer business.

146
00:07:03,400 --> 00:07:05,800
Speaker 3: We feel that they feel in fact that they can

147
00:07:05,839 --> 00:07:08,040
Speaker 3: stand better on their own two feet and be independent,

148
00:07:08,120 --> 00:07:10,720
Speaker 3: raise their own capital, take on their own projects, and

149
00:07:10,960 --> 00:07:12,920
Speaker 3: we want to support them in that it's the right

150
00:07:12,960 --> 00:07:16,440
Speaker 3: thing to do. Our capital should be allocated towards discovering

151
00:07:16,440 --> 00:07:19,239
Speaker 3: new medicines, and there should be about growing their business

152
00:07:19,240 --> 00:07:21,400
Speaker 3: fast in the market, which by the way, they're doing

153
00:07:21,480 --> 00:07:24,760
Speaker 3: very successfully. We've declared that buy as early as Q

154
00:07:24,840 --> 00:07:28,440
Speaker 3: four twenty four will be ready to go to separate

155
00:07:28,480 --> 00:07:31,200
Speaker 3: that business. We haven't shared how we will do it,

156
00:07:31,240 --> 00:07:32,680
Speaker 3: but I think it's quite.

157
00:07:32,480 --> 00:07:33,240
Speaker 1: Well known that.

158
00:07:33,880 --> 00:07:37,880
Speaker 3: You know, we're talking to interesting parties, certainly Pe, and

159
00:07:37,920 --> 00:07:41,960
Speaker 3: we have the capital markets vehicles available to us too,

160
00:07:42,080 --> 00:07:45,520
Speaker 3: So no, we're excited for them. There's a huge amount

161
00:07:45,560 --> 00:07:48,240
Speaker 3: of interest. It's a great business and we hope to

162
00:07:48,240 --> 00:07:51,520
Speaker 3: create value for patients, for stakeholders, and indeed for the

163
00:07:51,560 --> 00:07:52,440
Speaker 3: people in the business.

164
00:07:52,720 --> 00:07:57,760
Speaker 2: Q four twenty four is pretty notable given that we're

165
00:07:57,800 --> 00:08:01,200
Speaker 2: in quite a politically uncertain time. Look, we two brips

166
00:08:01,200 --> 00:08:03,000
Speaker 2: sit here looking that there's going to be an election

167
00:08:03,320 --> 00:08:05,920
Speaker 2: and people voting in the UK tomorrow and then of

168
00:08:05,960 --> 00:08:08,720
Speaker 2: course this weekend is all important for France. How as

169
00:08:08,720 --> 00:08:11,040
Speaker 2: a leader of such a French giant, are you feeling

170
00:08:11,080 --> 00:08:13,920
Speaker 2: about the political risk of doing a deal in this market?

171
00:08:15,560 --> 00:08:18,320
Speaker 3: Well, look, you know, in terms of healthcare and being

172
00:08:18,320 --> 00:08:21,160
Speaker 3: a leader of an incredibly important French company, you know,

173
00:08:21,200 --> 00:08:24,480
Speaker 3: our first priority is to ensure that whoever governs, they

174
00:08:24,520 --> 00:08:28,040
Speaker 3: provide a predictable, stable environment. Because research is a ten

175
00:08:28,080 --> 00:08:31,520
Speaker 3: to fifteen year process, so you know, we need to

176
00:08:31,560 --> 00:08:34,040
Speaker 3: think long term. We hope that whoever leads the country

177
00:08:34,280 --> 00:08:36,560
Speaker 3: will think long term. We know the current government has

178
00:08:36,600 --> 00:08:40,160
Speaker 3: been incredibly supportive of innovation and creating that ecosystem. We

179
00:08:40,240 --> 00:08:42,120
Speaker 3: hope that that would continue.

180
00:08:42,320 --> 00:08:42,880
Speaker 1: Of course.

181
00:08:43,160 --> 00:08:45,600
Speaker 3: You know, there are people trying to understand what it

182
00:08:45,679 --> 00:08:48,880
Speaker 3: means for the economy, much like for the change in

183
00:08:48,960 --> 00:08:51,880
Speaker 3: government if it's to come about in the UK, and

184
00:08:52,120 --> 00:08:55,040
Speaker 3: people want that predictability in the markets too. You know,

185
00:08:55,200 --> 00:08:57,880
Speaker 3: we're long term player, trying to do the right things

186
00:08:57,880 --> 00:09:00,680
Speaker 3: for patients, trying to drug the undruggable, and we hope

187
00:09:00,760 --> 00:09:03,880
Speaker 3: to partner with whoever's in power, of course, because we

188
00:09:04,040 --> 00:09:06,240
Speaker 3: have to be ready to do our part for society

189
00:09:06,280 --> 00:09:10,120
Speaker 3: and and you know, so far we believe that can continue.

190
00:09:10,440 --> 00:09:13,600
Speaker 2: Paul, it's been great talking to you the intersection of

191
00:09:13,679 --> 00:09:17,400
Speaker 2: drug discovery of artificial intelligence slackable AI as you call it.

192
00:09:17,440 --> 00:09:20,119
Speaker 2: Paul Hudson, great to have some time. CEO of Sanofie

193
00:09:20,400 --> 00:09:20,840
Speaker 2: say well,